Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Short Interest Down 71.9% in June

Phio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Free Report) was the target of a significant drop in short interest in June. As of June 30th, there was short interest totalling 25,400 shares, a drop of 71.9% from the June 15th total of 90,300 shares. Approximately 1.7% of the company’s stock are sold short. Based on an […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,United States , ,Phio Pharmaceuticals Company Profile ,Phio Pharmaceuticals ,Phio Pharmaceuticals Corp ,News Ratings For Phio Pharmaceuticals Daily ,Cambridge Investment Research Advisors Inc ,Nasdaq ,Vanguard Group Inc ,Renaissance Technologies ,Institutional Investors Weigh In On Phio Pharmaceuticals ,Phio Pharmaceuticals Price Performance ,Get Free Report ,Investment Research Advisors ,Investment Advisers ,Vanguard Group ,Natural Killer ,Phio Pharmaceuticals Daily ,Nasdaq Phio ,Ephio ,Medical ,Stocks ,Options ,Put ,Call ,